loader
Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (DMF) for 31651 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Ajinomoto Company

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Ajinomoto Company

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    Boulder Peptide 2024
    Not Confirmed

    01

    Ajinomoto Co Inc

    Japan
    arrow
    Boulder Peptide 2024
    Not Confirmed

    GDUFA

    DMF Review : Complete

    Rev. Date : 2021-08-27

    Pay. Date : 2020-11-30

    DMF Number : 31651

    Submission : 2017-04-20

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Looking for Drug Master Files (DMF) for 31651 of Ajinomoto Co Inc

    Looking for Drug Master Files (DMF) for 31651 of Ajinomoto Co Inc 1

    20

    Ajinomoto Co Inc, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is L-LYSINE MONOHYDROCHLORIDE, with a corresponding US DMF Number 31651.

    Remarkably, this DMF maintains an Active status since its submission on April 20, 2017, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of August 27, 2021, and payment made on November 30, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II